{"ticker": {"uuid": "21a4da2f-a2ec-4359-ac6e-52003a6fc1f9", "symbol": "FEMY", "name": "Femasys Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Femasys Inc. (FEMY) Slips 4% After Recent Rally; Key Support Tested - Low Volatility Picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPa3hOaFhFZ0ZZNVdScTNmcWEwVnpROTV5S2J0c0s5OVNkMW85eS1OVm52dkV6VnJEcWpTT19TblBkeWdOelh6TWZranFHeWEwNXZxMXRoSXl0bF9pVk5scEhod3hYT2FNNG9FYVJsVTh1TjNybDJURm1YaFNpclJjZ0d5MEVVNU03RFY1VGVtNlNJc1ltX0EteE5peHNBTGZZNGNweGRKQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-05T16:38:01+00:00", "published_display": "05 Jul 2026 16:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMY - Femasys Inc Earnings", "summary": "This page provides a detailed financial overview of Femasys Inc. (FEMY), including its last closing price, key financial metrics like market cap, income, and sales, and various performance indicators. It covers essential data such as EPS, sales growth, insider/institutional owner", "url": "https://finviz.com/stock?t=FEMY&ty=ea&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-02T14:41:06", "published_display": "02 Jul 2026 14:41", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMY - Femasys Inc Options", "summary": "This article provides a comprehensive overview of Femasys Inc (FEMY) stock options and key financial metrics. It details the company's last close price, dollar and percentage changes, market capitalization, enterprise value, and various financial ratios. The report also includes ", "url": "https://finviz.com/stock?t=FEMY&ty=oc&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-02T14:41:06", "published_display": "02 Jul 2026 14:41", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Regains Nasdaq Compliance After Reverse Stock Split", "summary": "Femasys Inc. (FEMY) has successfully regained compliance with Nasdaq's minimum bid price requirement following a 1-for-20 reverse stock split executed on June 5, 2026. This move resolves a delisting risk, allowing the company to concentrate on commercializing its reproductive hea", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2650461/femasys-regains-nasdaq-compliance-after-reverse-stock-split/", "source_name": "The Globe and Mail", "published_at": "2026-06-29T16:12:14", "published_display": "29 Jun 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (FEMY) investors back directors and KPMG auditor at 2026 meeting", "summary": "Femasys Inc. held its Annual Meeting of Stockholders where shareholders elected two Class II directors, Charles Larsen and Kenneth Eichenbaum, for three-year terms. They also ratified the appointment of KPMG LLP as the independent registered accounting firm for the fiscal year en", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-b3d0a11a059b.html", "source_name": "Stock Titan", "published_at": "2026-06-24T20:09:26", "published_display": "24 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Regains Nasdaq Compliance and Expands Global Access to Innovative Fertility and Birth Control Solutions", "summary": "Femasys Inc. (NASDAQ: FEMY) has regained compliance with Nasdaq's minimum bid price requirement, removing a significant overhang on its stock. The company is focused on advancing its fertility and non-surgical birth control solutions, including FemaSeed for infertility and FemBlo", "url": "https://www.minichart.com.sg/2026/06/24/femasys-regains-nasdaq-compliance-and-expands-global-access-to-innovative-fertility-and-birth-control-solutions/", "source_name": "Minichart", "published_at": "2026-06-24T15:11:15", "published_display": "24 Jun 2026 15:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Regains Compliance With Nasdaq Minimum Bid Price Rule", "summary": "Femasys Inc. announced it has regained compliance with Nasdaq's minimum bid price rule. This means the company's common stock has achieved a closing bid price of at least $1.00 for ten consecutive business days, satisfying Listing Rule 5550(a)(2). As a result, the previously anno", "url": "https://www.moomoo.com/news/post/71975216/femasys-regains-compliance-with-nasdaq-minimum-bid-price-rule", "source_name": "Moomoo", "published_at": "2026-06-24T15:09:26", "published_display": "24 Jun 2026 15:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys regains Nasdaq minimum bid compliance after 1-for-20 reverse split", "summary": "Femasys (FEMY) has successfully regained compliance with Nasdaq's $1.00 minimum bid requirement. This achievement follows a 1-for-20 reverse stock split that became effective on June 5, 2026, with the company's closing bid price remaining above $1.00 for 10 consecutive business d", "url": "https://www.tradingview.com/news/tradingview:be9f38ac12de5:0-femasys-regains-nasdaq-minimum-bid-compliance-after-1-for-20-reverse-split/", "source_name": "TradingView", "published_at": "2026-06-24T14:09:26", "published_display": "24 Jun 2026 14:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Regains Compliance with Nasdaq Listing Requirements", "summary": "Femasys Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement for continued listing, with the matter now officially closed. CEO Kathy Lee-Sepsick stated that this development is important for the company and its shareholders, allowing Femasys to fo", "url": "https://www.globenewswire.com/news-release/2026/06/24/3316880/0/en/femasys-regains-compliance-with-nasdaq-listing-requirements.html", "source_name": "GlobeNewswire", "published_at": "2026-06-24T13:09:26", "published_display": "24 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (NASDAQ: FEMY) back in compliance with Nasdaq listing requirements", "summary": "Femasys Inc. (NASDAQ: FEMY) has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, following a 1-for-20 reverse stock split that became effective on June 5, 2026. The company's closing bid price remained at or above $1.00 for ten consecutive busin", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-beeefeb1363d.html", "source_name": "Stock Titan", "published_at": "2026-06-24T13:09:26", "published_display": "24 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Inc (FEMY) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Femasys Inc (FEMY) has a current financial score of 4.73, ranking 201 out of 204 in the Healthcare Equipment & Supplies industry. The company's financial status is stable with low operating efficiency, despite a recent 24.50% year-over-year revenue increase and a 114.35% year-ove", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-femy/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T05:38:57", "published_display": "18 Jun 2026 05:38", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Inc (FEMY) Institutional Confidence", "summary": "This article from TradingKey focuses on the institutional confidence in Femasys Inc (FEMY). It details the institutional shareholding, including the top shareholders and the changes in their held shares, indicating a mix of increased and decreased positions among major investors.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-femy/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T05:38:57", "published_display": "18 Jun 2026 05:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Inc (FEMY) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Femasys Inc (FEMY) stock, focusing on its dividend and stock split history. It notes that Femasys Inc has not distributed any dividends over the past five years and details one upcoming merger-related stock split scheduled for June 4, 2026. Th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-femy/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T17:10:40", "published_display": "17 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Inc (FEMY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Femasys Inc (FEMY). It lists financial periods for which revenue data is typically disclosed, noting that relevant data has not yet been provided by the company for specific segments. The only disclosed regional revenue shows the Unit", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-femy/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T17:10:40", "published_display": "17 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Announces 1-for-20 Reverse Stock Split Implementation", "summary": "Femasys Inc. (FEMY) has implemented a 1-for-20 reverse stock split on June 5, 2026, following stockholder authorization. This action aims to help the company maintain Nasdaq listing compliance and potentially improve its per-share trading price. The stock is scheduled to trade on", "url": "https://www.theglobeandmail.com/investing/markets/stocks/FEMY/pressreleases/2343060/femasys-announces-1-for-20-reverse-stock-split-implementation/", "source_name": "The Globe and Mail", "published_at": "2026-06-10T21:09:26", "published_display": "10 Jun 2026 21:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (NASDAQ: FEMY) implements 1-for-20 reverse stock split", "summary": "Femasys Inc. (NASDAQ: FEMY) has completed a 1-for-20 reverse stock split, effective 8:40 a.m. Eastern Time on June 5, 2026. This action consolidates every 20 outstanding shares into one, with no change to the $0.001 par value, and proportionately adjusts all stock options, RSUs, ", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-81064323f710.html", "source_name": "Stock Titan", "published_at": "2026-06-05T20:09:56", "published_display": "05 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Announces 1-for-20 Reverse Stock Split Initiative", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPWFVoNC1WZlBiaXBGNUczODFSMlJhX2tFLTQxalV4YkY4b3M1UHFWWjJSVF9XWXJNZTBrbVp0SThpYTZRcDd1dTk3OFM4dU9Zb3l6XzRIMm5zSk9WTU1pSTcyNjBiRHJtWWdaVzQ3MGI5bFY5MXlvUzJrU05KYXNMMk8wOTMxa1BKWTI2Y0dJekF2OXBwb2hPeElUaFRHZGg3QkN3Zkt4alZ0Q1hpa1VBNHJWVEpRTkFaVjVzaWlxNHptdWs1dXdCYVVUTUZ2dXMwMURQZw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys to implement 1-for-20 reverse stock split; trading symbol FEMY unchanged", "summary": "Femasys (FEMY) announced a 1-for-20 reverse stock split of its common stock, effective June 5, 2026, at 4:30 p.m. ET. Shares will trade on a split-adjusted basis from market open on June 8, with the trading symbol remaining FEMY and a new CUSIP. Each 20 pre-split shares will conv", "url": "https://www.tradingview.com/news/tradingview:a76c95a036f0e:0-femasys-to-implement-1-for-20-reverse-stock-split-trading-symbol-femy-unchanged/", "source_name": "TradingView", "published_at": "2026-06-04T12:40:00", "published_display": "04 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reverse split will consolidate Femasys (NASDAQ: FEMY) common shares 20-to-1", "summary": "Femasys Inc. (NASDAQ: FEMY) announced a 1-for-20 reverse stock split of its common shares, effective at 4:30 p.m. Eastern Time on June 5, 2026. Each 20 pre-split shares will convert into one post-split share, with fractional shares rounded up to the nearest whole share. Split-adj", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-6f15ffbad8fa.html", "source_name": "Stock Titan", "published_at": "2026-06-04T12:40:00", "published_display": "04 Jun 2026 12:40", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys, Inc. Financial Disclosures & SEC Filings", "summary": "This page provides access to Femasys Inc.'s financial disclosures and SEC filings, including Forms 10-K, 10-Q, and 8-K. Users can explore various documents to evaluate the company's financial performance and operational updates. The listings include earnings reports and corporate", "url": "https://www.tradingview.com/symbols/NASDAQ-FEMY/documents/", "source_name": "TradingView", "published_at": "2026-06-03T10:09:47", "published_display": "03 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMY - Femasys Inc Stock Price and Quote", "summary": "This article provides comprehensive financial data and recent news for Femasys Inc. (FEMY). It includes stock performance metrics, valuation ratios, insider and institutional ownership, and a detailed chronological list of company announcements and events, highlighting developmen", "url": "https://finviz.com/stock?t=FEMY", "source_name": "Finviz", "published_at": "2026-06-01T12:12:14", "published_display": "01 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMY Technical Analysis & Stock Price Forecast", "summary": "Femasys Inc (FEMY) currently has a \"Strong Sell\" technical sentiment, according to an analysis based on 9 technical signals where 7 indicate sell and 2 indicate buy as of May 29, 2026. The stock is trading below its 60-day ($0.44) and 200-day ($0.569) moving averages, with a curr", "url": "https://intellectia.ai/en/stock/FEMY/technical", "source_name": "Intellectia AI", "published_at": "2026-06-01T08:39:35", "published_display": "01 Jun 2026 08:39", "sentiment": "negative", "sentiment_pct": 13, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Maintains Femasys(FEMY.US) With Buy Rating, Maintains Target Price $1.5", "summary": "Maxim Group has reiterated its Buy rating for Femasys (FEMY.US) and maintained its price target of $1.5. This indicates a continued positive outlook from the firm regarding Femasys' stock performance.", "url": "https://www.moomoo.com/news/post/70016917/maxim-group-maintains-femasys-femyus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-05-14T20:39:26", "published_display": "14 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG\u2122 Catheter", "summary": "Femasys Inc. announced CE Mark approval for its FemHSG\u2122 Catheter, expanding its fertility care portfolio in Europe. This catheter, used with the FemVue\u00ae device, supports efficient in-office fertility evaluations. The approval aims to improve access to timely and affordable fertil", "url": "https://www.sahmcapital.com/news/content/femasys-expands-fertility-care-portfolio-in-europe-with-ce-mark-approval-for-femhsg-catheter-2026-05-13", "source_name": "Sahm", "published_at": "2026-05-14T17:09:20", "published_display": "14 May 2026 17:09", "sentiment": "positive", "sentiment_pct": 75, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys receives CE Mark approval for FemHSG fertility catheter", "summary": "Femasys Inc. has received CE Mark approval for its FemHSG Catheter, expanding its fertility product portfolio in Europe. This catheter, designed for in-office fertility evaluation, works with the FemVue device for uterine and fallopian tube assessment. Despite a recent stock decl", "url": "https://m.uk.investing.com/news/stock-market-news/femasys-receives-ce-mark-approval-for-femhsg-fertility-catheter-93CH-4674718?ampMode=1", "source_name": "Investing.com UK", "published_at": "2026-05-14T03:38:56", "published_display": "14 May 2026 03:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (NASDAQ: FEMY) outlines FemaSeed fertility and FemBloc birth control strategy", "summary": "Femasys Inc. filed an 8-K to present an updated corporate presentation detailing its women's reproductive health portfolio and growth strategy. The presentation focuses on FemaSeed for in-office fertility treatment and FemBloc, a non-surgical permanent birth control undergoing a ", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-fba152761d52.html", "source_name": "Stock Titan", "published_at": "2026-05-14T03:09:33", "published_display": "14 May 2026 03:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys updates corporate presentation on women\u2019s health portfolio", "summary": "Femasys (FEMY) has released an updated corporate slide presentation for investors, analysts, and other stakeholders. The presentation highlights the company's diverse women's health portfolio, which includes fertility solutions and non-surgical permanent birth control products, a", "url": "https://www.tipranks.com/news/company-announcements/femasys-updates-corporate-presentation-on-womens-health-portfolio", "source_name": "TipRanks", "published_at": "2026-05-13T22:09:33", "published_display": "13 May 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys posts updated corporate presentation detailing fertility and FemBloc commercialization plans", "summary": "Femasys (FEMY) has released an updated corporate presentation outlining its commercial strategy, clinical progress, and near-term milestones for its fertility and non-surgical permanent birth control solutions. Key highlights include FemaSeed's clinical data showing a ~2x pregnan", "url": "https://www.tradingview.com/news/tradingview:28bc69a6479a5:0-femasys-posts-updated-corporate-presentation-detailing-fertility-and-fembloc-commercialization-plans/", "source_name": "TradingView", "published_at": "2026-05-13T21:09:33", "published_display": "13 May 2026 21:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New in-office fertility catheter approved in Europe to support faster diagnosis", "summary": "Femasys (NASDAQ: FEMY) has received CE Mark approval for its FemHSG Catheter, allowing it to expand its fertility care portfolio in Europe. This catheter, used with the FemVue device, enables streamlined, in-office ultrasound-based evaluation during initial fertility workups, mak", "url": "https://www.stocktitan.net/news/FEMY/femasys-expands-fertility-care-portfolio-in-europe-with-ce-mark-nspl078jcs0f.html", "source_name": "Stock Titan", "published_at": "2026-05-13T13:09:04", "published_display": "13 May 2026 13:09", "sentiment": "positive", "sentiment_pct": 85, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Reverse Stock Split May Not Prevent Nasdaq Delisting Risk, Observer Warns", "summary": "An external observer warns that a reverse stock split by Femasys, Inc. (FEMY) to comply with Nasdaq's minimum bid price may not guarantee sustained compliance. The observer suggests that the post-split price increase might be temporary, and Femasys could still fail other Nasdaq c", "url": "https://www.theglobeandmail.com/investing/markets/stocks/FEMY-Q/pressreleases/1841738/femasys-reverse-stock-split-may-not-prevent-nasdaq-delisting-risk-observer-warns/", "source_name": "The Globe and Mail", "published_at": "2026-05-11T14:39:25", "published_display": "11 May 2026 14:39", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxNeVc4bEt0czdXaVJPYUNpX2ozdU1ueGN0YlZvZlZFeEt1WWh5djQ3S3lmUjRsTG9LQkRYMEhma2dqUGJQanBoVHdBRUJZZmZGdzhySlVuNzdjdFNyTXhrU0FnRDdEeXdkR2JRVG10Q2xMNGNGSnlURGhlcWVXdWlkS1lEdnhJdU16OU5MUFdYekljUUktODhfWFN6d3BnZzFoUkxhWHVDTzNhV2FzQkNBZzR4TndJcWVMbmxhMk1WcEllWEhITmRnREEtVF9YeDdBQzQzQ1lLNXVGbWpsMHMyVHpRTU5DcHpSbDlVWE5ZempJblRMSlQyb3pCOG9Fdw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed\u00ae Complete", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/femasys-enables-ob-gyns-deliver-130000197.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T13:00:00+00:00", "published_display": "05 May 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys pushes fertility treatment into OB/GYN offices with first paid use", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOZGlQN3FuX1ZoMExDd2xmNjBrSVp4SVpYR19UVUkyRHl3aG1XV2hiZUhUVi14UkxtX0pGZ2VMU2lYMGlGYlBhMktLVlV2eFdrT2NGQ2lvMFpwZGk2VWdlWUx3UlRtM1A2NTl6MVdJNW9YblJvME4wLVFSR3FZY0xWUExHWlhfdkZTX0RtRFVEZ0U4MExnek8xUGU5cmxqb0dEMHFTTU5Vc3d2LWJBVllSNll5X0JObzZlQU5JNUR3?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Launches FemaSeed\u00ae Complete for OB/GYNs at ACOG 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/femasys-launches-femaseed-complete-ob-130000250.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T13:00:00+00:00", "published_display": "22 Apr 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys aims to bring first-line fertility treatment into OB/GYN offices", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQcGE0T1BDQVktdklOY3ZpTVY4OGxrZ0hvQXdXVTJESEFzc2taakxrRzFHX2FNejU2UTNFUVpIa1JQY3o2X1RPNDViLTQ3R284TTRIOGNWNWY2ZFo3VVh0QklHQ3hoNW1uenp6Nlk1RGpUcnhrNk5CVWJTRGhXN1drajQ2cTE1VElraU0zRmNwVnJvcXNLTXgxelZ4YXNnU1NuTmFWeEdGcm85SjFRWWVOSg?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medtech veteran joins Femasys to scale fertility, birth control products", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQeXFXazJZSjJ4MUFkdTlXMjVxOHhlOUZFc1VYXzhuNS1nV1pxMWpkR1lrQ0pKSTdnMDB4cW45VFpDTkhqWG5maERfS0pwWjVBVGdoTGJnaF91SXRTN05aSnJHUFByTERoOUhpcWt0RzNtajZjbXhabjBnVnF5dXRTY2xieG5WamU4RFc2emx4M2dMNzRjOTVWRkNEXzVNVWo3dk5OS0twdmMtT055WWxLUF9fUHl3bzVzekFvYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxQTDBKZ3B4c3JGUTFFaHM0VzE5RXp4aHVYV3NXUFlFU1p5MF9CMEJaTF9Fam9zT25yaHp2VGR2eUxDZ0RuTU9xQm5iYU9EeDQxN1UzTXJ6d3plaTloR2pvc1M2NHJRSVhwWE1LMjJsYTZoN0lYYTF0alVaSmZZMW5CcXp3bWkwUXl1bVhTRUJJTFlqOUVEZkp6Y2draG5qbDlXWUtFdm5lTWNfb1AyTVJDY29OOGk1Umd5bDhqbzRqd0RHalpOZG9mclAxOVVsZGpVSDBxOUc2dFk1b1JoWGNXY0xBeUtaNFRfR3VWdUpUQVBCLXFYNXQyZ1I4a0dxdw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Receives Nasdaq Extension to Regain Listing Compliance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPVXdLTFFyY2RmZUZlaVhxYUNDNzY4SEVQM3ZMRVAzQXZyQlZyZGZlMFRiSzJsSE55c182N0tzbTBxRVBfdUNIQWQ2cmlRSFkzZE45bl92aVN0Uy0tUmtMWUkxSmM1TkFLWEFES1ltOUVwSGw3M1M5V0Vqd213N3NBU0h5SVQtdFBlZng2dlZEWnh4UUpMTUdxYkNhS2g0UW14d2JrY1k4cFk4TTNON2ZNckdjOThsQmxyZlM1OXE3c2tlNG9mVG9IM19HakVuWFJEN1FTVm1udFhDS0RF?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOR0lPVi1lOHpxU0tBVUp6bmlOdms5ckdlcjZyd2ptT3VUY0M5UVgxYy03VjlpNzJINkgzY3FvYml0NGFsVGxtOG95RV9uMmhwU2o5S0pmQ0dvbUlVU2p3M3VLOU95T0ZRVUg5dl84dTFhUkg0MFZYTGQzRWlVLURHTTctemVCUVY1Sl9ITTk4cFdoakZyZi1kVjBQbDA5cXJtZ1ltbFdaMlhLUzY1UnlBZFFza2lzdGl0aHJMZWdvemktekh3Qzd6OA?oc=5", "source_name": "Investing.com", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOd19SbFJSQ3RXdTA4RFhrcjZJbzZ0NENRNW9TU21fYmNhWHZ6MmpqTHFoeGZYUDM2TV95MXBQYloydktxZGtNNmxCWWJyU0ZRaWVtM1hXMDQzSXFpTGMxd2ZoQVItSndJWHprVWxrbVhydWxaWmQwZjFVLUJCc3ZYbk5tb1hlQQ?oc=5", "source_name": "Market source", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Stock Drop Looks Sharp, But How Deep Can It Go?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPYVlaZ2JIYkdjRG9TYWZUYUV3dzBVU3F2UlM4dWd1ekVCQjNfbGRnemtCVmo1bzBRbVFHOU1xdmZ5LVIzcDJPT19DR1JHSV90R3V3M2luYjhUaDRlbk1nZHFDdUZOYVg2WlREb3VaYnZEVUZobDYtVThxQWF6WGxscUE4RGVXYUJ0SWI1SXpSazd1UHB2cC1FazF3dW54T2NfQmlVejNMb1NRZjUzSWd5M3hJLUwzOFl6UVFQSk1fdTVoUQ?oc=5", "source_name": "Trefis", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PMCB Stock Jumps 25% After Company Sells Stake In Femasys", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOaVhHemV5UjdsaU11Z0poUDRkczkwdmdnbWY2NkZtTmpkbk5sQ1g1LUFnOXlRTThtUGU3NU9OS1U1aHQtOE9xMGVfNTQtSjN3Mkw3MHdNSi0zdDZPNXFwTHpoNk94ekhzZjZNaWRLdzhmRm96MUtBYWJRaU9GQW5fZmd1V2pSV0xtaTI0TjVZcVllV1FLN2dOUzZMbExsYnVnZ2NSSTRtLWNIR2Z5WkhxdHdHa1g5WDAx?oc=5", "source_name": "Stocktwits", "published_at": "2025-11-25T08:00:00+00:00", "published_display": "25 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Secures FDA Approval to Advance Final FemBloc\u00ae", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxNV3VkTzNzUDdZdVA1OGdNZU9LZjBLbGE5WDEtR3BKdGM0SnNKNW1OOXRhcndTNE5WblpqMFZwNlBDR3dtUVMta25lWGF1ZjhlTWw2WVpmN0pWUlp6a1hSWkRhNkRSeWEzMlFqRmp6WmNwbFhOQkhsb3VZUHJDdFNucEduc0RlMDNrVDNLaU83dGNVMUZMX1FmUlpxWlVRRkxhQjV1aUNZaVJiX3hVcHVGb1hlQ1Z0UjhFS3NkM3FhTFN4ZEJaWVhfeUFheDEydkZ5WGJlSzVKLTBUUE9XTmdzc29OR3FkXzNDenVrVU1LQXVtSy1HVXc1aFNVaF9WSGJJSkgxNmxTNVlEazRGUWEzS2VVZmc0SUdUU0hDd2ZBSVRWUmc?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMASYS (FEMY) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE42ZWJXcHMyOGc4VjB1Z2NuU09OTUJOMzI1ZzhsaU5FNmFFMXRXME9tc3o1eVBNNWdLcE1HUWpTVEZnOG01NS1fS2N2Um9hTWVGa0hn?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T23:56:45+00:00", "published_display": "24 Apr 2025 23:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (NASDAQ: FEMY) down 50% - Well, that little rally died quickly then", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOQjN3NVhDakxzSXJOMmhfRkhIbWNoc2pzTTQ1MEVJMU9LUzFDNzBvZ2F6MjhxVVN2YlNwamlaSWM4ck5tYW5Va1ZhQTlhWEF6OV9NU3kwMnN0cUU4OHBxX0RyRkpROHJ1c0pVNlNYTHNHT2lsSU9yb2YyVW5qM1BuMGx6R0NjQzJMTWp6S1d3czBKbWpHNjNkVTN30gGfAUFVX3lxTE9Fb0o5YUhwekYtWEpFU0w1T1EwVndMak9YMDdoN2RhcThfUnZybTA0dEhCbzBnUVdRODlySTVsTEpYQWEyLU4xQTJFN2V6NUI3cVpydWhVdW01aW43MGtGMFNodTI1UV85SFRhSGFIVFZVQmsyT25qQmJDd21tX3FUVlUwUzdORlhaN3lnUEdJeTR0bmRyZTVsVDBkYlRHOA?oc=5", "source_name": "Dhaka Tribune", "published_at": "2023-10-04T07:00:00+00:00", "published_display": "04 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Femasys Inc. (FEMY) Slips 4% After Recent Rally; Key Support Tested - Low Volatility Picks", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPa3hOaFhFZ0ZZNVdScTNmcWEwVnpROTV5S2J0c0s5OVNkMW85eS1OVm52dkV6VnJEcWpTT19TblBkeWdOelh6TWZranFHeWEwNXZxMXRoSXl0bF9pVk5scEhod3hYT2FNNG9FYVJsVTh1TjNybDJURm1YaFNpclJjZ0d5MEVVNU03RFY1VGVtNlNJc1ltX0EteE5peHNBTGZZNGNweGRKQQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-05T16:38:01+00:00", "published_display": "05 Jul 2026 16:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMY - Femasys Inc Earnings", "summary": "This page provides a detailed financial overview of Femasys Inc. (FEMY), including its last closing price, key financial metrics like market cap, income, and sales, and various performance indicators. It covers essential data such as EPS, sales growth, insider/institutional owner", "url": "https://finviz.com/stock?t=FEMY&ty=ea&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-02T14:41:06", "published_display": "02 Jul 2026 14:41", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMY - Femasys Inc Options", "summary": "This article provides a comprehensive overview of Femasys Inc (FEMY) stock options and key financial metrics. It details the company's last close price, dollar and percentage changes, market capitalization, enterprise value, and various financial ratios. The report also includes ", "url": "https://finviz.com/stock?t=FEMY&ty=oc&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-02T14:41:06", "published_display": "02 Jul 2026 14:41", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Regains Nasdaq Compliance After Reverse Stock Split", "summary": "Femasys Inc. (FEMY) has successfully regained compliance with Nasdaq's minimum bid price requirement following a 1-for-20 reverse stock split executed on June 5, 2026. This move resolves a delisting risk, allowing the company to concentrate on commercializing its reproductive hea", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2650461/femasys-regains-nasdaq-compliance-after-reverse-stock-split/", "source_name": "The Globe and Mail", "published_at": "2026-06-29T16:12:14", "published_display": "29 Jun 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (FEMY) investors back directors and KPMG auditor at 2026 meeting", "summary": "Femasys Inc. held its Annual Meeting of Stockholders where shareholders elected two Class II directors, Charles Larsen and Kenneth Eichenbaum, for three-year terms. They also ratified the appointment of KPMG LLP as the independent registered accounting firm for the fiscal year en", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-b3d0a11a059b.html", "source_name": "Stock Titan", "published_at": "2026-06-24T20:09:26", "published_display": "24 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Regains Nasdaq Compliance and Expands Global Access to Innovative Fertility and Birth Control Solutions", "summary": "Femasys Inc. (NASDAQ: FEMY) has regained compliance with Nasdaq's minimum bid price requirement, removing a significant overhang on its stock. The company is focused on advancing its fertility and non-surgical birth control solutions, including FemaSeed for infertility and FemBlo", "url": "https://www.minichart.com.sg/2026/06/24/femasys-regains-nasdaq-compliance-and-expands-global-access-to-innovative-fertility-and-birth-control-solutions/", "source_name": "Minichart", "published_at": "2026-06-24T15:11:15", "published_display": "24 Jun 2026 15:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Regains Compliance With Nasdaq Minimum Bid Price Rule", "summary": "Femasys Inc. announced it has regained compliance with Nasdaq's minimum bid price rule. This means the company's common stock has achieved a closing bid price of at least $1.00 for ten consecutive business days, satisfying Listing Rule 5550(a)(2). As a result, the previously anno", "url": "https://www.moomoo.com/news/post/71975216/femasys-regains-compliance-with-nasdaq-minimum-bid-price-rule", "source_name": "Moomoo", "published_at": "2026-06-24T15:09:26", "published_display": "24 Jun 2026 15:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys regains Nasdaq minimum bid compliance after 1-for-20 reverse split", "summary": "Femasys (FEMY) has successfully regained compliance with Nasdaq's $1.00 minimum bid requirement. This achievement follows a 1-for-20 reverse stock split that became effective on June 5, 2026, with the company's closing bid price remaining above $1.00 for 10 consecutive business d", "url": "https://www.tradingview.com/news/tradingview:be9f38ac12de5:0-femasys-regains-nasdaq-minimum-bid-compliance-after-1-for-20-reverse-split/", "source_name": "TradingView", "published_at": "2026-06-24T14:09:26", "published_display": "24 Jun 2026 14:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Regains Compliance with Nasdaq Listing Requirements", "summary": "Femasys Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement for continued listing, with the matter now officially closed. CEO Kathy Lee-Sepsick stated that this development is important for the company and its shareholders, allowing Femasys to fo", "url": "https://www.globenewswire.com/news-release/2026/06/24/3316880/0/en/femasys-regains-compliance-with-nasdaq-listing-requirements.html", "source_name": "GlobeNewswire", "published_at": "2026-06-24T13:09:26", "published_display": "24 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (NASDAQ: FEMY) back in compliance with Nasdaq listing requirements", "summary": "Femasys Inc. (NASDAQ: FEMY) has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, following a 1-for-20 reverse stock split that became effective on June 5, 2026. The company's closing bid price remained at or above $1.00 for ten consecutive busin", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-beeefeb1363d.html", "source_name": "Stock Titan", "published_at": "2026-06-24T13:09:26", "published_display": "24 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Inc (FEMY) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Femasys Inc (FEMY) has a current financial score of 4.73, ranking 201 out of 204 in the Healthcare Equipment & Supplies industry. The company's financial status is stable with low operating efficiency, despite a recent 24.50% year-over-year revenue increase and a 114.35% year-ove", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-femy/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T05:38:57", "published_display": "18 Jun 2026 05:38", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Inc (FEMY) Institutional Confidence", "summary": "This article from TradingKey focuses on the institutional confidence in Femasys Inc (FEMY). It details the institutional shareholding, including the top shareholders and the changes in their held shares, indicating a mix of increased and decreased positions among major investors.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-femy/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T05:38:57", "published_display": "18 Jun 2026 05:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Inc (FEMY) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Femasys Inc (FEMY) stock, focusing on its dividend and stock split history. It notes that Femasys Inc has not distributed any dividends over the past five years and details one upcoming merger-related stock split scheduled for June 4, 2026. Th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-femy/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T17:10:40", "published_display": "17 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Inc (FEMY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Femasys Inc (FEMY). It lists financial periods for which revenue data is typically disclosed, noting that relevant data has not yet been provided by the company for specific segments. The only disclosed regional revenue shows the Unit", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-femy/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T17:10:40", "published_display": "17 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Announces 1-for-20 Reverse Stock Split Implementation", "summary": "Femasys Inc. (FEMY) has implemented a 1-for-20 reverse stock split on June 5, 2026, following stockholder authorization. This action aims to help the company maintain Nasdaq listing compliance and potentially improve its per-share trading price. The stock is scheduled to trade on", "url": "https://www.theglobeandmail.com/investing/markets/stocks/FEMY/pressreleases/2343060/femasys-announces-1-for-20-reverse-stock-split-implementation/", "source_name": "The Globe and Mail", "published_at": "2026-06-10T21:09:26", "published_display": "10 Jun 2026 21:09", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (NASDAQ: FEMY) implements 1-for-20 reverse stock split", "summary": "Femasys Inc. (NASDAQ: FEMY) has completed a 1-for-20 reverse stock split, effective 8:40 a.m. Eastern Time on June 5, 2026. This action consolidates every 20 outstanding shares into one, with no change to the $0.001 par value, and proportionately adjusts all stock options, RSUs, ", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-81064323f710.html", "source_name": "Stock Titan", "published_at": "2026-06-05T20:09:56", "published_display": "05 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Announces 1-for-20 Reverse Stock Split Initiative", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPWFVoNC1WZlBiaXBGNUczODFSMlJhX2tFLTQxalV4YkY4b3M1UHFWWjJSVF9XWXJNZTBrbVp0SThpYTZRcDd1dTk3OFM4dU9Zb3l6XzRIMm5zSk9WTU1pSTcyNjBiRHJtWWdaVzQ3MGI5bFY5MXlvUzJrU05KYXNMMk8wOTMxa1BKWTI2Y0dJekF2OXBwb2hPeElUaFRHZGg3QkN3Zkt4alZ0Q1hpa1VBNHJWVEpRTkFaVjVzaWlxNHptdWs1dXdCYVVUTUZ2dXMwMURQZw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys to implement 1-for-20 reverse stock split; trading symbol FEMY unchanged", "summary": "Femasys (FEMY) announced a 1-for-20 reverse stock split of its common stock, effective June 5, 2026, at 4:30 p.m. ET. Shares will trade on a split-adjusted basis from market open on June 8, with the trading symbol remaining FEMY and a new CUSIP. Each 20 pre-split shares will conv", "url": "https://www.tradingview.com/news/tradingview:a76c95a036f0e:0-femasys-to-implement-1-for-20-reverse-stock-split-trading-symbol-femy-unchanged/", "source_name": "TradingView", "published_at": "2026-06-04T12:40:00", "published_display": "04 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reverse split will consolidate Femasys (NASDAQ: FEMY) common shares 20-to-1", "summary": "Femasys Inc. (NASDAQ: FEMY) announced a 1-for-20 reverse stock split of its common shares, effective at 4:30 p.m. Eastern Time on June 5, 2026. Each 20 pre-split shares will convert into one post-split share, with fractional shares rounded up to the nearest whole share. Split-adj", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-6f15ffbad8fa.html", "source_name": "Stock Titan", "published_at": "2026-06-04T12:40:00", "published_display": "04 Jun 2026 12:40", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys, Inc. Financial Disclosures & SEC Filings", "summary": "This page provides access to Femasys Inc.'s financial disclosures and SEC filings, including Forms 10-K, 10-Q, and 8-K. Users can explore various documents to evaluate the company's financial performance and operational updates. The listings include earnings reports and corporate", "url": "https://www.tradingview.com/symbols/NASDAQ-FEMY/documents/", "source_name": "TradingView", "published_at": "2026-06-03T10:09:47", "published_display": "03 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMY - Femasys Inc Stock Price and Quote", "summary": "This article provides comprehensive financial data and recent news for Femasys Inc. (FEMY). It includes stock performance metrics, valuation ratios, insider and institutional ownership, and a detailed chronological list of company announcements and events, highlighting developmen", "url": "https://finviz.com/stock?t=FEMY", "source_name": "Finviz", "published_at": "2026-06-01T12:12:14", "published_display": "01 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMY Technical Analysis & Stock Price Forecast", "summary": "Femasys Inc (FEMY) currently has a \"Strong Sell\" technical sentiment, according to an analysis based on 9 technical signals where 7 indicate sell and 2 indicate buy as of May 29, 2026. The stock is trading below its 60-day ($0.44) and 200-day ($0.569) moving averages, with a curr", "url": "https://intellectia.ai/en/stock/FEMY/technical", "source_name": "Intellectia AI", "published_at": "2026-06-01T08:39:35", "published_display": "01 Jun 2026 08:39", "sentiment": "negative", "sentiment_pct": 13, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Maintains Femasys(FEMY.US) With Buy Rating, Maintains Target Price $1.5", "summary": "Maxim Group has reiterated its Buy rating for Femasys (FEMY.US) and maintained its price target of $1.5. This indicates a continued positive outlook from the firm regarding Femasys' stock performance.", "url": "https://www.moomoo.com/news/post/70016917/maxim-group-maintains-femasys-femyus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-05-14T20:39:26", "published_display": "14 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG\u2122 Catheter", "summary": "Femasys Inc. announced CE Mark approval for its FemHSG\u2122 Catheter, expanding its fertility care portfolio in Europe. This catheter, used with the FemVue\u00ae device, supports efficient in-office fertility evaluations. The approval aims to improve access to timely and affordable fertil", "url": "https://www.sahmcapital.com/news/content/femasys-expands-fertility-care-portfolio-in-europe-with-ce-mark-approval-for-femhsg-catheter-2026-05-13", "source_name": "Sahm", "published_at": "2026-05-14T17:09:20", "published_display": "14 May 2026 17:09", "sentiment": "positive", "sentiment_pct": 75, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys receives CE Mark approval for FemHSG fertility catheter", "summary": "Femasys Inc. has received CE Mark approval for its FemHSG Catheter, expanding its fertility product portfolio in Europe. This catheter, designed for in-office fertility evaluation, works with the FemVue device for uterine and fallopian tube assessment. Despite a recent stock decl", "url": "https://m.uk.investing.com/news/stock-market-news/femasys-receives-ce-mark-approval-for-femhsg-fertility-catheter-93CH-4674718?ampMode=1", "source_name": "Investing.com UK", "published_at": "2026-05-14T03:38:56", "published_display": "14 May 2026 03:38", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (NASDAQ: FEMY) outlines FemaSeed fertility and FemBloc birth control strategy", "summary": "Femasys Inc. filed an 8-K to present an updated corporate presentation detailing its women's reproductive health portfolio and growth strategy. The presentation focuses on FemaSeed for in-office fertility treatment and FemBloc, a non-surgical permanent birth control undergoing a ", "url": "https://www.stocktitan.net/sec-filings/FEMY/8-k-femasys-inc-reports-material-event-fba152761d52.html", "source_name": "Stock Titan", "published_at": "2026-05-14T03:09:33", "published_display": "14 May 2026 03:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys updates corporate presentation on women\u2019s health portfolio", "summary": "Femasys (FEMY) has released an updated corporate slide presentation for investors, analysts, and other stakeholders. The presentation highlights the company's diverse women's health portfolio, which includes fertility solutions and non-surgical permanent birth control products, a", "url": "https://www.tipranks.com/news/company-announcements/femasys-updates-corporate-presentation-on-womens-health-portfolio", "source_name": "TipRanks", "published_at": "2026-05-13T22:09:33", "published_display": "13 May 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys posts updated corporate presentation detailing fertility and FemBloc commercialization plans", "summary": "Femasys (FEMY) has released an updated corporate presentation outlining its commercial strategy, clinical progress, and near-term milestones for its fertility and non-surgical permanent birth control solutions. Key highlights include FemaSeed's clinical data showing a ~2x pregnan", "url": "https://www.tradingview.com/news/tradingview:28bc69a6479a5:0-femasys-posts-updated-corporate-presentation-detailing-fertility-and-fembloc-commercialization-plans/", "source_name": "TradingView", "published_at": "2026-05-13T21:09:33", "published_display": "13 May 2026 21:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New in-office fertility catheter approved in Europe to support faster diagnosis", "summary": "Femasys (NASDAQ: FEMY) has received CE Mark approval for its FemHSG Catheter, allowing it to expand its fertility care portfolio in Europe. This catheter, used with the FemVue device, enables streamlined, in-office ultrasound-based evaluation during initial fertility workups, mak", "url": "https://www.stocktitan.net/news/FEMY/femasys-expands-fertility-care-portfolio-in-europe-with-ce-mark-nspl078jcs0f.html", "source_name": "Stock Titan", "published_at": "2026-05-13T13:09:04", "published_display": "13 May 2026 13:09", "sentiment": "positive", "sentiment_pct": 85, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Reverse Stock Split May Not Prevent Nasdaq Delisting Risk, Observer Warns", "summary": "An external observer warns that a reverse stock split by Femasys, Inc. (FEMY) to comply with Nasdaq's minimum bid price may not guarantee sustained compliance. The observer suggests that the post-split price increase might be temporary, and Femasys could still fail other Nasdaq c", "url": "https://www.theglobeandmail.com/investing/markets/stocks/FEMY-Q/pressreleases/1841738/femasys-reverse-stock-split-may-not-prevent-nasdaq-delisting-risk-observer-warns/", "source_name": "The Globe and Mail", "published_at": "2026-05-11T14:39:25", "published_display": "11 May 2026 14:39", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxNeVc4bEt0czdXaVJPYUNpX2ozdU1ueGN0YlZvZlZFeEt1WWh5djQ3S3lmUjRsTG9LQkRYMEhma2dqUGJQanBoVHdBRUJZZmZGdzhySlVuNzdjdFNyTXhrU0FnRDdEeXdkR2JRVG10Q2xMNGNGSnlURGhlcWVXdWlkS1lEdnhJdU16OU5MUFdYekljUUktODhfWFN6d3BnZzFoUkxhWHVDTzNhV2FzQkNBZzR4TndJcWVMbmxhMk1WcEllWEhITmRnREEtVF9YeDdBQzQzQ1lLNXVGbWpsMHMyVHpRTU5DcHpSbDlVWE5ZempJblRMSlQyb3pCOG9Fdw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed\u00ae Complete", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/femasys-enables-ob-gyns-deliver-130000197.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T13:00:00+00:00", "published_display": "05 May 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys pushes fertility treatment into OB/GYN offices with first paid use", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOZGlQN3FuX1ZoMExDd2xmNjBrSVp4SVpYR19UVUkyRHl3aG1XV2hiZUhUVi14UkxtX0pGZ2VMU2lYMGlGYlBhMktLVlV2eFdrT2NGQ2lvMFpwZGk2VWdlWUx3UlRtM1A2NTl6MVdJNW9YblJvME4wLVFSR3FZY0xWUExHWlhfdkZTX0RtRFVEZ0U4MExnek8xUGU5cmxqb0dEMHFTTU5Vc3d2LWJBVllSNll5X0JObzZlQU5JNUR3?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Launches FemaSeed\u00ae Complete for OB/GYNs at ACOG 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/femasys-launches-femaseed-complete-ob-130000250.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T13:00:00+00:00", "published_display": "22 Apr 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys aims to bring first-line fertility treatment into OB/GYN offices", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQcGE0T1BDQVktdklOY3ZpTVY4OGxrZ0hvQXdXVTJESEFzc2taakxrRzFHX2FNejU2UTNFUVpIa1JQY3o2X1RPNDViLTQ3R284TTRIOGNWNWY2ZFo3VVh0QklHQ3hoNW1uenp6Nlk1RGpUcnhrNk5CVWJTRGhXN1drajQ2cTE1VElraU0zRmNwVnJvcXNLTXgxelZ4YXNnU1NuTmFWeEdGcm85SjFRWWVOSg?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medtech veteran joins Femasys to scale fertility, birth control products", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQeXFXazJZSjJ4MUFkdTlXMjVxOHhlOUZFc1VYXzhuNS1nV1pxMWpkR1lrQ0pKSTdnMDB4cW45VFpDTkhqWG5maERfS0pwWjVBVGdoTGJnaF91SXRTN05aSnJHUFByTERoOUhpcWt0RzNtajZjbXhabjBnVnF5dXRTY2xieG5WamU4RFc2emx4M2dMNzRjOTVWRkNEXzVNVWo3dk5OS0twdmMtT055WWxLUF9fUHl3bzVzekFvYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxQTDBKZ3B4c3JGUTFFaHM0VzE5RXp4aHVYV3NXUFlFU1p5MF9CMEJaTF9Fam9zT25yaHp2VGR2eUxDZ0RuTU9xQm5iYU9EeDQxN1UzTXJ6d3plaTloR2pvc1M2NHJRSVhwWE1LMjJsYTZoN0lYYTF0alVaSmZZMW5CcXp3bWkwUXl1bVhTRUJJTFlqOUVEZkp6Y2draG5qbDlXWUtFdm5lTWNfb1AyTVJDY29OOGk1Umd5bDhqbzRqd0RHalpOZG9mclAxOVVsZGpVSDBxOUc2dFk1b1JoWGNXY0xBeUtaNFRfR3VWdUpUQVBCLXFYNXQyZ1I4a0dxdw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Receives Nasdaq Extension to Regain Listing Compliance", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPVXdLTFFyY2RmZUZlaVhxYUNDNzY4SEVQM3ZMRVAzQXZyQlZyZGZlMFRiSzJsSE55c182N0tzbTBxRVBfdUNIQWQ2cmlRSFkzZE45bl92aVN0Uy0tUmtMWUkxSmM1TkFLWEFES1ltOUVwSGw3M1M5V0Vqd213N3NBU0h5SVQtdFBlZng2dlZEWnh4UUpMTUdxYkNhS2g0UW14d2JrY1k4cFk4TTNON2ZNckdjOThsQmxyZlM1OXE3c2tlNG9mVG9IM19HakVuWFJEN1FTVm1udFhDS0RF?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOR0lPVi1lOHpxU0tBVUp6bmlOdms5ckdlcjZyd2ptT3VUY0M5UVgxYy03VjlpNzJINkgzY3FvYml0NGFsVGxtOG95RV9uMmhwU2o5S0pmQ0dvbUlVU2p3M3VLOU95T0ZRVUg5dl84dTFhUkg0MFZYTGQzRWlVLURHTTctemVCUVY1Sl9ITTk4cFdoakZyZi1kVjBQbDA5cXJtZ1ltbFdaMlhLUzY1UnlBZFFza2lzdGl0aHJMZWdvemktekh3Qzd6OA?oc=5", "source_name": "Investing.com", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOd19SbFJSQ3RXdTA4RFhrcjZJbzZ0NENRNW9TU21fYmNhWHZ6MmpqTHFoeGZYUDM2TV95MXBQYloydktxZGtNNmxCWWJyU0ZRaWVtM1hXMDQzSXFpTGMxd2ZoQVItSndJWHprVWxrbVhydWxaWmQwZjFVLUJCc3ZYbk5tb1hlQQ?oc=5", "source_name": "Market source", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Stock Drop Looks Sharp, But How Deep Can It Go?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPYVlaZ2JIYkdjRG9TYWZUYUV3dzBVU3F2UlM4dWd1ekVCQjNfbGRnemtCVmo1bzBRbVFHOU1xdmZ5LVIzcDJPT19DR1JHSV90R3V3M2luYjhUaDRlbk1nZHFDdUZOYVg2WlREb3VaYnZEVUZobDYtVThxQWF6WGxscUE4RGVXYUJ0SWI1SXpSazd1UHB2cC1FazF3dW54T2NfQmlVejNMb1NRZjUzSWd5M3hJLUwzOFl6UVFQSk1fdTVoUQ?oc=5", "source_name": "Trefis", "published_at": "2025-12-23T08:00:00+00:00", "published_display": "23 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PMCB Stock Jumps 25% After Company Sells Stake In Femasys", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOaVhHemV5UjdsaU11Z0poUDRkczkwdmdnbWY2NkZtTmpkbk5sQ1g1LUFnOXlRTThtUGU3NU9OS1U1aHQtOE9xMGVfNTQtSjN3Mkw3MHdNSi0zdDZPNXFwTHpoNk94ekhzZjZNaWRLdzhmRm96MUtBYWJRaU9GQW5fZmd1V2pSV0xtaTI0TjVZcVllV1FLN2dOUzZMbExsYnVnZ2NSSTRtLWNIR2Z5WkhxdHdHa1g5WDAx?oc=5", "source_name": "Stocktwits", "published_at": "2025-11-25T08:00:00+00:00", "published_display": "25 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys Secures FDA Approval to Advance Final FemBloc\u00ae", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxNV3VkTzNzUDdZdVA1OGdNZU9LZjBLbGE5WDEtR3BKdGM0SnNKNW1OOXRhcndTNE5WblpqMFZwNlBDR3dtUVMta25lWGF1ZjhlTWw2WVpmN0pWUlp6a1hSWkRhNkRSeWEzMlFqRmp6WmNwbFhOQkhsb3VZUHJDdFNucEduc0RlMDNrVDNLaU83dGNVMUZMX1FmUlpxWlVRRkxhQjV1aUNZaVJiX3hVcHVGb1hlQ1Z0UjhFS3NkM3FhTFN4ZEJaWVhfeUFheDEydkZ5WGJlSzVKLTBUUE9XTmdzc29OR3FkXzNDenVrVU1LQXVtSy1HVXc1aFNVaF9WSGJJSkgxNmxTNVlEazRGUWEzS2VVZmc0SUdUU0hDd2ZBSVRWUmc?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FEMASYS (FEMY) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE42ZWJXcHMyOGc4VjB1Z2NuU09OTUJOMzI1ZzhsaU5FNmFFMXRXME9tc3o1eVBNNWdLcE1HUWpTVEZnOG01NS1fS2N2Um9hTWVGa0hn?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T23:56:45+00:00", "published_display": "24 Apr 2025 23:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Femasys (NASDAQ: FEMY) down 50% - Well, that little rally died quickly then", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOQjN3NVhDakxzSXJOMmhfRkhIbWNoc2pzTTQ1MEVJMU9LUzFDNzBvZ2F6MjhxVVN2YlNwamlaSWM4ck5tYW5Va1ZhQTlhWEF6OV9NU3kwMnN0cUU4OHBxX0RyRkpROHJ1c0pVNlNYTHNHT2lsSU9yb2YyVW5qM1BuMGx6R0NjQzJMTWp6S1d3czBKbWpHNjNkVTN30gGfAUFVX3lxTE9Fb0o5YUhwekYtWEpFU0w1T1EwVndMak9YMDdoN2RhcThfUnZybTA0dEhCbzBnUVdRODlySTVsTEpYQWEyLU4xQTJFN2V6NUI3cVpydWhVdW01aW43MGtGMFNodTI1UV85SFRhSGFIVFZVQmsyT25qQmJDd21tX3FUVlUwUzdORlhaN3lnUEdJeTR0bmRyZTVsVDBkYlRHOA?oc=5", "source_name": "Dhaka Tribune", "published_at": "2023-10-04T07:00:00+00:00", "published_display": "04 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 45, "sentiment_summary": {"positive": 14, "negative": 6, "neutral": 25, "score": 55, "total": 45, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 17.05, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 3.3, "count": 6}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 14, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 3.99, "latest_week": "2026-07-10", "one_week_move": -4.3, "four_week_move": -4.5, "twelve_week_move": -52.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.164496, "market_dynamics_buy_signal": false, "relative_strength": -70.22603, "fair_value_gap": -78.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.6427, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.3% over one week, -4.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 65, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 10}, {"label": "GlobeNewswire", "count": 6}, {"label": "The Globe and Mail", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "TradingKey", "count": 4}, {"label": "Finviz", "count": 3}, {"label": "Moomoo", "count": 2}, {"label": "dars.gov.et", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 6}, {"label": "Regulatory and legal", "count": 4}, {"label": "Deals and strategy", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.3% over one week, -4.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Femasys Inc. (FEMY) Slips 4% After Recent Rally; Key Support Tested - Low Volatility Picks"}], "updated_at": "2026-07-16T11:42:42.148821+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}